Kyverna Upsized $319M IPO Signals Surge in Life Sciences Market

0
189

Amidst a dynamic tapestry of market volatility, Kyverna’s foray into the public arena stands as a testament to unwavering determination and visionary leadership in the pursuit of transformative therapies.